tiprankstipranks
Trending News
More News >
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market

Cumberland Pharmaceuticals (CPIX) Ratios

Compare
226 Followers

Cumberland Pharmaceuticals Ratios

CPIX's free cash flow for Q3 2025 was $0.88. For the 2025 fiscal year, CPIX's free cash flow was decreased by $ and operating cash flow was $-0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.23 1.28 1.60 2.37 1.95
Quick Ratio
1.11 1.11 1.28 1.93 1.53
Cash Ratio
0.63 0.65 0.69 1.40 0.96
Solvency Ratio
0.05 >-0.01 >-0.01 -0.02 -0.04
Operating Cash Flow Ratio
0.28 0.22 0.30 0.33 0.21
Short-Term Operating Cash Flow Coverage
17.02 0.00 0.00 0.00 2.48
Net Current Asset Value
$ -10.16M$ -16.80M$ -11.08M$ 3.83M$ 379.68K
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.23 0.23 0.19 0.18
Debt-to-Equity Ratio
0.39 0.62 0.58 0.38 0.36
Debt-to-Capital Ratio
0.28 0.38 0.37 0.27 0.27
Long-Term Debt-to-Capital Ratio
0.17 0.30 0.31 0.26 0.24
Financial Leverage Ratio
2.52 2.76 2.56 1.97 2.05
Debt Service Coverage Ratio
2.43 0.16 0.45 -9.11 -0.66
Interest Coverage Ratio
-5.38 -9.30 -9.74 -78.32 -24.21
Debt to Market Cap
0.19 0.50 0.49 0.22 0.38
Interest Debt Per Share
0.73 1.34 1.48 1.08 1.14
Net Debt to EBITDA
-2.07 0.70 3.61 12.80 4.93
Profitability Margins
Gross Profit Margin
84.49%84.66%78.29%75.51%76.89%
EBIT Margin
-6.71%-14.20%-11.89%-15.18%-16.84%
EBITDA Margin
5.81%0.39%0.79%-2.38%-4.16%
Operating Profit Margin
-7.90%-15.70%-13.58%-21.34%-17.04%
Pretax Profit Margin
-8.18%-15.89%-13.29%-15.46%-17.55%
Net Profit Margin
-8.06%-15.88%-13.45%-15.55%-17.70%
Continuous Operations Profit Margin
-8.09%-16.01%-13.45%-15.55%-17.70%
Net Income Per EBT
98.54%99.91%101.23%100.63%100.85%
EBT Per EBIT
103.52%101.19%97.83%72.45%102.95%
Return on Assets (ROA)
-5.05%-7.68%-6.08%-6.63%-6.87%
Return on Equity (ROE)
-12.60%-21.21%-15.58%-13.07%-14.10%
Return on Capital Employed (ROCE)
-7.85%-11.55%-8.87%-11.78%-9.01%
Return on Invested Capital (ROIC)
-7.58%-11.55%-8.95%-11.68%-8.70%
Return on Tangible Assets
-6.66%-10.78%-9.20%-9.39%-9.82%
Earnings Yield
-11.24%-24.53%-17.24%-8.04%-14.81%
Efficiency Ratios
Receivables Turnover
3.96 4.05 3.19 5.23 3.02
Payables Turnover
0.46 0.43 0.84 0.91 0.65
Inventory Turnover
2.18 1.32 0.97 1.05 0.81
Fixed Asset Turnover
5.25 5.62 7.63 24.53 14.39
Asset Turnover
0.63 0.48 0.45 0.43 0.39
Working Capital Turnover Ratio
6.42 3.16 1.92 1.42 1.49
Cash Conversion Cycle
-529.06 -477.20 57.55 19.59 4.32
Days of Sales Outstanding
92.23 90.05 114.37 69.76 120.67
Days of Inventory Outstanding
167.31 277.32 376.25 349.20 448.74
Days of Payables Outstanding
788.60 844.58 433.07 399.37 565.08
Operating Cycle
259.54 367.37 490.62 418.96 569.40
Cash Flow Ratios
Operating Cash Flow Per Share
0.46 0.43 0.58 0.43 0.36
Free Cash Flow Per Share
0.45 0.39 0.44 0.40 0.22
CapEx Per Share
<0.01 0.03 0.14 0.02 0.14
Free Cash Flow to Operating Cash Flow
0.98 0.93 0.75 0.94 0.61
Dividend Paid and CapEx Coverage Ratio
54.80 13.45 4.08 17.89 2.56
Capital Expenditure Coverage Ratio
54.80 13.45 4.08 17.89 2.56
Operating Cash Flow Coverage Ratio
0.67 0.33 0.40 0.39 0.32
Operating Cash Flow to Sales Ratio
0.17 0.15 0.20 0.18 0.14
Free Cash Flow Yield
22.65%22.04%19.47%8.60%7.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.90 -4.08 -5.80 -12.44 -6.75
Price-to-Sales (P/S) Ratio
0.72 0.65 0.78 1.93 1.19
Price-to-Book (P/B) Ratio
1.13 0.86 0.90 1.63 0.95
Price-to-Free Cash Flow (P/FCF) Ratio
4.41 4.54 5.14 11.62 13.55
Price-to-Operating Cash Flow Ratio
4.33 4.20 3.88 10.97 8.26
Price-to-Earnings Growth (PEG) Ratio
0.98 -0.32 -2.20 0.91 0.25
Price-to-Fair Value
1.13 0.86 0.90 1.63 0.95
Enterprise Value Multiple
10.28 167.64 102.03 -68.34 -23.79
Enterprise Value
24.66M 25.70M 33.97M 58.62M 37.05M
EV to EBITDA
10.28 167.64 102.03 -68.34 -23.79
EV to Sales
0.60 0.65 0.81 1.63 0.99
EV to Free Cash Flow
3.68 4.56 5.32 9.79 11.22
EV to Operating Cash Flow
3.61 4.22 4.02 9.24 6.84
Tangible Book Value Per Share
0.66 0.40 0.31 1.19 1.18
Shareholders’ Equity Per Share
1.75 2.07 2.49 2.87 3.10
Tax and Other Ratios
Effective Tax Rate
0.02 >-0.01 -0.01 >-0.01 >-0.01
Revenue Per Share
2.76 2.77 2.88 2.41 2.47
Net Income Per Share
-0.22 -0.44 -0.39 -0.38 -0.44
Tax Burden
0.99 1.00 1.01 1.01 1.01
Interest Burden
1.22 1.12 1.12 1.02 1.04
Research & Development to Revenue
0.13 0.15 0.16 0.16 0.15
SG&A to Revenue
0.27 0.27 0.24 0.27 0.27
Stock-Based Compensation to Revenue
<0.01 <0.01 0.01 0.02 0.03
Income Quality
-2.05 -0.97 -1.50 -1.76 -1.58
Currency in USD